Mosale Seetharam Sumanth, Liu Yi, Wu Jason, Fechter Lenn, Murugesan Kanagavel, Maecker Holden, Gotlib Jason, Zehnder James, Paulmurugan Ramasamy, Krishnan Anandi
Department of Pathology, Stanford University, Stanford, CA.
Department of Radiology, Stanford University, Stanford, CA.
bioRxiv. 2023 Jan 12:2023.01.07.523111. doi: 10.1101/2023.01.07.523111.
Impaired protein homeostasis, though well established in age-related disorders, has been linked in recent research with the pathogenesis of myeloproliferative neoplasms (MPNs). As yet, however, little is known about MPN-specific modulators of proteostasis, thus impeding our ability for increased mechanistic understanding and discovery of additional therapeutic targets. Loss of proteostasis, in itself, is traced to dysregulated mechanisms in protein folding and intracellular calcium signaling at the endoplasmic reticulum (ER). Here, using and systems (including cultures from patient bone marrow, and healthy cord/peripheral blood specimens), we extend our prior data from MPN patient platelet RNA sequencing, and discover select proteostasis-associated markers at RNA and/or protein levels in each of platelets, parent megakaryocytes, and whole blood specimens. Importantly, we identify a novel role in MPNs for enkurin ( ), a calcium mediator protein, implicated originally only in spermatogenesis. Our data reveal consistent downregulation at both RNA and protein levels across MPN patient specimens and experimental models, with a concomitant upregulation of a cell cycle marker, . Silencing of by shRNA in CD34 derived megakaryocytes further confirm this association with at both RNA and protein levels; and indicate a likely role for the pathway. The inverse association of and expression was further confirmed upon treatment with thapsigargin (an agent that causes protein misfolding in the ER by selective loss of calcium) in both megakaryocyte and platelet fractions at RNA and protein levels. Together, our work sheds light on enkurin as a novel marker of MPN pathogenesis beyond the genetic alterations; and indicates further mechanistic investigation into a role for dysregulated calcium homeostasis, and ER and protein folding stress in MPN transformation.
Enkurin, a calcium adaptor protein, is identified as a novel marker of pathogenesis in MPNs.MPN megakaryocyte and platelet expression of enkurin at RNA and protein levels is inversely associated with a cell differentiation cycle gene, CDC20.Likely role for dysregulated calcium homeostasis, and ER and protein folding stress in MPN transformation.
蛋白质稳态受损在年龄相关疾病中已得到充分证实,最近的研究将其与骨髓增殖性肿瘤(MPN)的发病机制联系起来。然而,迄今为止,关于MPN特异性蛋白质稳态调节剂知之甚少,这阻碍了我们深入理解其机制并发现更多治疗靶点的能力。蛋白质稳态的丧失本身可追溯到内质网(ER)中蛋白质折叠和细胞内钙信号传导的失调机制。在这里,我们使用细胞系和原代细胞系统(包括来自患者骨髓的原代细胞培养物以及健康脐带/外周血标本),扩展了我们之前对MPN患者血小板RNA测序的数据,并在血小板、母巨核细胞和全血标本的RNA和/或蛋白质水平上发现了一些与蛋白质稳态相关的标志物。重要的是,我们确定了enkurin(一种钙介质蛋白,最初仅被认为与精子发生有关)在MPN中的新作用。我们的数据显示,在MPN患者标本和实验模型中,enkurin在RNA和蛋白质水平均持续下调,同时细胞周期标志物CDC20上调。在CD34+来源的巨核细胞中通过shRNA沉默enkurin进一步在RNA和蛋白质水平证实了其与CDC20的这种关联;并表明CDC20通路可能发挥作用。在用毒胡萝卜素(一种通过选择性钙缺失导致内质网中蛋白质错误折叠的药物)处理后,在巨核细胞和血小板组分的RNA和蛋白质水平上,enkurin和CDC20表达的负相关进一步得到证实。总之,我们的工作揭示了enkurin作为MPN发病机制中除基因改变之外的一个新标志物;并表明需要进一步深入研究钙稳态失调、内质网和蛋白质折叠应激在MPN转化中的作用机制。
钙衔接蛋白enkurin被确定为MPN发病机制的一个新标志物。MPN巨核细胞和血小板中enkurin在RNA和蛋白质水平的表达与细胞分化周期基因CDC20呈负相关。钙稳态失调、内质网和蛋白质折叠应激在MPN转化中可能发挥作用。